Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
monarcHER: Abemaciclib in HR+, HER2+ Advanced Breast Cancer
NCT02675231Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of abemaciclib in breast cancer, sponsored by Eli Lilly and Company. Started May 2016; status: completed.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02675231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02675231.